Moleculin Biotech, Inc. Earnings Per Share, Basic and Diluted
Moleculin Biotech, Inc. (MBRX) reported Earnings Per Share, Basic and Diluted of -$0.59 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-24
- Moleculin Biotech, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.15.
- Moleculin Biotech, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.15.
- Moleculin Biotech, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.20.
- Moleculin Biotech, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.33.
- Moleculin Biotech, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.59.
- Moleculin Biotech, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.76.
- Moleculin Biotech, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.95.
- Moleculin Biotech, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.46.
| Period end | Earnings Per Share, Basic and Diluted 2 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 5 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.59 10-K · filed 2022-03-24 | |||||||||
| 2021-09-30 | -$0.15 10-Q · filed 2021-11-10 | -$0.50 10-Q · filed 2021-11-10 | ||||||||
| 2021-06-30 | -$0.15 10-Q · filed 2021-08-11 | -$0.35 10-Q · filed 2021-08-11 | ||||||||
| 2021-03-31 | -$0.20 10-Q · filed 2021-05-12 | |||||||||
| 2020-12-31 | -$1.76 10-K · filed 2022-03-24 | |||||||||
| 2020-09-30 | -$0.33 10-Q · filed 2021-11-10 | -$0.06 10-Q · filed 2020-11-12 | -$1.55 10-Q · filed 2021-11-10 | -$0.26 10-Q · filed 2020-11-12 | ||||||
| 2020-06-30 | -$1.02 10-Q · filed 2021-08-11 | -$0.17 10-Q · filed 2020-08-12 | -$1.24 10-Q · filed 2021-08-11 | -$0.21 10-Q · filed 2020-08-12 | ||||||
| 2020-03-31 | -$0.15 10-Q · filed 2021-05-12 | -$0.02 10-Q · filed 2020-05-11 | ||||||||
| 2019-12-31 | -$1.95 10-K · filed 2021-03-24 | -$0.32 10-K · filed 2020-03-19 | ||||||||
| 2019-09-30 | -$0.09 10-Q · filed 2020-11-12 | -$0.24 10-Q · filed 2020-11-12 | ||||||||
| 2019-06-30 | -$0.03 10-Q · filed 2020-08-12 | -$0.15 10-Q · filed 2020-08-12 | ||||||||
| 2019-03-31 | -$0.14 10-Q · filed 2020-05-11 | |||||||||
| 2018-12-31 | -$0.46 10-K · filed 2020-03-19 | |||||||||
| 2018-09-30 | -$0.08 10-Q · filed 2019-11-12 | -$0.36 10-Q · filed 2019-11-12 | ||||||||
| 2018-06-30 | -$0.20 10-Q · filed 2019-08-16 | -$0.29 10-Q · filed 2019-08-16 | ||||||||
| 2018-03-31 | -$0.08 10-Q · filed 2019-05-13 | |||||||||
| 2017-12-31 | -$0.53 10-K · filed 2019-02-21 | |||||||||
| 2017-09-30 | -$0.14 10-Q · filed 2018-11-13 | -$0.37 10-Q · filed 2018-11-13 | ||||||||
| 2017-06-30 | -$0.19 10-Q · filed 2018-08-10 | -$0.23 10-Q · filed 2018-08-10 | ||||||||
| 2017-03-31 | -$0.02 10-Q · filed 2018-05-14 | |||||||||
| 2016-12-31 | -$0.40 10-K · filed 2018-03-28 | |||||||||
| 2016-09-30 | -$0.12 10-Q · filed 2017-11-13 | -$0.28 10-Q · filed 2017-11-13 | ||||||||
| 2016-06-30 | -$0.08 10-Q · filed 2017-08-11 | -$0.11 10-Q · filed 2016-08-15 | -$0.14 10-Q · filed 2017-08-11 | -$0.17 10-Q · filed 2016-08-15 | ||||||
| 2016-03-31 | -$0.05 10-Q · filed 2017-05-12 | |||||||||
| 2015-12-31 | -$0.13 10-K · filed 2017-04-03 | |||||||||
| 2015-09-30 | -$0.05 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |